In Vitro Tests in Drug Hypersensitivity Diagnosis

Immunology and Allergy Clinics of North America

Volumn 29, Issue 3, 2009, Pages 537-554

  Lochmatter, Priska ^a   Zawodniak, Anna ^a   Pichler, Werner J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

CD69 upregulation; Cytokines; Cytotoxicity; Drug hypersensitivity; In vitro tests; Lymphocyte transformation test

Indexed keywords

ABACAVIR; AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CARBAMAZEPINE; DICLOFENAC; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANZYME B; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 8; LAMOTRIGINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PHENYTOIN; PYRAZOLONE DERIVATIVE; SULFONAMIDE; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

ALLERGY TEST; AUTOIMMUNE HEPATITIS; CELLULAR IMMUNITY; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DIFFERENTIAL DIAGNOSIS; DRESS SYNDROME; DRUG ERUPTION; DRUG HYPERSENSITIVITY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; IMMUNOPATHOGENESIS; INTRACUTANEOUS TEST; LYMPHOCYTE TRANSFORMATION TEST; PATCH TEST; PRICK TEST; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SKIN TEST; T LYMPHOCYTE ACTIVATION; TOXIC HEPATITIS;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; BIOLOGICAL MARKERS; CYTOKINES; CYTOTOXICITY TESTS, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNOGLOBULIN E; IMMUNOLOGIC TESTS; LYMPHOCYTE ACTIVATION; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MEDICAL HISTORY TAKING; T-CELL ANTIGEN RECEPTOR SPECIFICITY; T-LYMPHOCYTES;

EID: 67649373967     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2009.04.009     Document Type: Review

References (109)

1. Hunziker T., Bruppacher R., Kuenzi U.P., et al. Classification of ADRs: a proposal for harmonization and differentiation based on the experience of the comprehensive hospital drug monitoring Bern/St. Gallen, 1974-1993. Pharmacoepidemiol Drug Saf 11 2 (2002) 159-163
2. Coombs P.R., and Gell P.G. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Gell R.R. (Ed). Clinical Aspects of Immunology (1968), Oxford University Press, Oxford 575-596
3. Pichler W.J. Delayed drug hypersensitivity reactions. Ann Intern Med 139 8 (2003) 683-693
4. Torres M.J., Romano A., Mayorga C., et al. Diagnostic evaluation of a large group of patients with immediate allergy to penicillins: the role of skin testing. Allergy 56 9 (2001) 850-856
5. Torres M.J., Blanca M., Fernandez J., et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 58 10 (2003) 961-972
6. Romano A., Blanca M., Torres M.J., et al. Diagnosis of nonimmediate reactions to beta-lactam antibiotics. Allergy 59 11 (2004) 1153-1160
7. Padial A., Antunez C., Blanca-Lopez N., et al. Non-immediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test. Clin Exp Allergy 38 5 (2008) 822-828
8. Bousquet P.J., Pipet A., Bousquet-Rouanet L., et al. Oral challenges are needed in the diagnosis of beta-lactam hypersensitivity. Clin Exp Allergy 38 1 (2008) 185-190
9. Posadas S.J., and Pichler W.J. Delayed drug hypersensitivity reactions-new concepts. Clin Exp Allergy 37 7 (2007) 989-999
10. Britschgi M., Steiner U.C., Schmid S., et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 107 11 (2001) 1433-1441
11. Yawalkar N., Egli F., Hari Y., et al. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin Exp Allergy 30 6 (2000) 847-855
12. Schnyder B., Frutig K., Mauri-Hellweg D., et al. T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazole-induced skin reaction. Clin Exp Allergy 28 11 (1998) 1412-1417
13. Nassif A., Bensussan A., Boumsell L., et al. Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells. J Allergy Clin Immunol 114 5 (2004) 1209-1215
14. Naisbitt D.J., Gordon S.F., Pirmohamed M., et al. Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment. Drug Saf 23 6 (2000) 483-507
15. Padovan E., Bauer T., Tongio M.M., et al. Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy. Eur J Immunol 27 6 (1997) 1303-1307
16. Lu L., Vollmer J., Moulon C., et al. Components of the ligand for a Ni++ reactive human T cell clone. J Exp Med 197 5 (2003) 567-574
17. Gallucci S., and Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 13 1 (2001) 114-119
18. Park B.K., Pirmohamed M., and Kitteringham N.R. Role of drug disposition in drug hypersensitivity: a chemical, molecular, and clinical perspective. Chem Res Toxicol 11 (1998) 969-987
19. Brander C., Mauri-Hellweg D., Bettens F., et al. Heterogeneous T cell responses to beta-lactam-modified self-structures are observed in penicillin-allergic individuals. J Immunol 155 5 (1995) 2670-2678
20. Yawalkar N., Hari Y., Frutig K., et al. T cells isolated from positive epicutaneous test reactions to amoxicillin and ceftriaxone are drug specific and cytotoxic. J Invest Dermatol 115 4 (2000) 647-652
21. Zanni M.P., Mauri-Hellweg D., Brander C., et al. Characterization of lidocaine-specific T cells. J Immunol 158 3 (1997) 1139-1148
22. Mauri-Hellweg D., Bettens F., Mauri D., et al. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 155 1 (1995) 462-472
23. Hertl M., Geisel J., Boecker C., et al. Selective generation of CD8+ T-cell clones from the peripheral blood of patients with cutaneous reactions to beta-lactam antibiotics. Br J Dermatol 128 6 (1993) 619-626
24. Sieben S., Kawakubo Y., Al Masaoudi T., et al. Delayed-type hypersensitivity reaction to paraphenylenediamine is mediated by 2 different pathways of antigen recognition by specific alphabeta human T-cell clones. J Allergy Clin Immunol 109 6 (2002) 1005-1011
25. Schmid D.A., Depta J.P., and Pichler W.J. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. Clin Exp Allergy 36 1 (2006) 59-69
26. Pichler W.J., Beeler A., Keller M., et al. Pharmacological interaction of drugs with immune receptors: the p-i concept. Allergol Int 55 1 (2006) 17-25
27. Pichler W.J. Lessons from drug allergy: against dogmata. Curr Allergy Asthma Rep 3 1 (2003) 1-3
28. Beeler A., Engler O., Gerber B.O., et al. Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions. J Allergy Clin Immunol 117 2 (2006) 455-462
29. von Greyerz S., Bultemann G., Schnyder K., et al. Degeneracy and additional alloreactivity of drug-specific human alpha beta(+) T cell clones. Int Immunol 13 7 (2001) 877-885
30. Cerdan C., Martin Y., Courcoul M., et al. CD28 costimulation regulates long-term expression of the three genes (alpha, beta, gamma) encoding the high-affinity IL2 receptor. Res Immunol 146 3 (1995) 164-168
31. Park H., Li Z., Yang X.O., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6 11 (2005) 1133-1141
32. Harrington L.E., Hatton R.D., Mangan P.R., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6 11 (2005) 1123-1132
33. Langrish C.L., Chen Y., Blumenschein W.M., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201 2 (2005) 233-240
34. Bluestone J.A., and Abbas A.K. Natural versus adaptive regulatory T cells. Nat Rev Immunol 3 3 (2003) 253-257
35. Hari Y., Frutig-Schnyder K., Hurni M., et al. T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 31 9 (2001) 1398-1408
36. Luque I., Leyva L., Jose Torres M., et al. In vitro T-cell responses to beta-lactam drugs in immediate and nonimmediate allergic reactions. Allergy 56 7 (2001) 611-618
37. Naisbitt D.J., Britschgi M., Wong G., et al. Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones. Mol Pharmacol 63 3 (2003) 732-741
38. Naisbitt D.J., Farrell J., Wong G., et al. Characterization of drug-specific T cells in lamotrigine hypersensitivity. J Allergy Clin Immunol 111 6 (2003) 1393-1403
39. Osterwalder P., Koch J., Wuthrich B., et al. [Intermittent fever of unknown origin]. Dtsch Med Wochenschr 123 24 (1998) 761-765 [in German]
40. Straumann A., Bauer M., Pichler W.J., et al. Acute pancreatitis due to pyritinol: an immune-mediated phenomenon. Gastroenterology 115 2 (1998) 452-454
41. Berger D., Pichler W., Savic S., et al. Fever pneumonia and eosinophilia. Praxis 96 40 (2007) 1543-1547 [in German]
42. Pichler W.J. Drug-induced autoimmunity. Curr Opin Allergy Clin Immunol 3 4 (2003) 249-253
43. Maria V.A., and Victorino R.M. Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury. Gut 41 (1997) 534-540
44. Tsutsui H., Terano Y., Sakagami C., et al. Drug-specific T cells derived from patients with drug-induced allergic hepatitis. J Immunol 149 2 (1992) 706-716
45. Schreiber J., Zissel G., Greinert U., et al. Lymphocyte transformation test for the evaluation of adverse effects of antituberculous drugs. Eur J Med Res 4 2 (1999) 67-71
46. Lerch M., Keller M., Britschgi M., et al. Cross-reactivity patterns of T cells specific for iodinated contrast media. J Allergy Clin Immunol 119 6 (2007) 1529-1536
47. Pichler W.J., and Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 59 8 (2004) 809-820
48. Roujeau J.C., Albengres E., and Moritz S. Lymphocyte transformation test in drug-induced toxic epidermal necrolysis. Int Arch Allergy Appl Immunol 78 (1985) 22-24
49. Nyfeler B., and Pichler W.J. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 27 2 (1997) 175-181
50. Neukomm C.B., Yawalkar N., Helbling A., et al. T-cell reactions to drugs in distinct clinical manifestations of drug allergy. J Investig Allergol Clin Immunol 11 4 (2001) 275-284
51. Everness K.M., Gawkrodger D.J., Botham P.A., et al. The discrimination between nickel-sensitive and non-nickel-sensitive subjects by an in vitro lymphocyte transformation test. Br J Dermatol 122 3 (1990) 293-298
52. Warrington R.J., and Tse K.S. Lymphocyte transformation studies in drug hypersensitivity. Can Med Assoc J 120 (1979) 1089-1094
53. Barna B.P., Gogate P., Deodhar S.D., et al. Lymphocyte transformation and radioallergenosorbent tests in drug hypersensitivity. Am J Clin Pathol 73 2 (1980) 172-176
54. Berg P.A., Brattig N., Diao G.-J., et al. Diagnose arzneimittelbedingter Nebenwirkungen mit Hilfe des Lyphozytentransformationstests. Allergologie 6 (1983) 77-81 [in German]
55. Walker C., Kristensen F., Bettens F., et al. Lymphokine regulation of activated (G1) lymphocytes. I. Prostaglandin E2-induced inhibition of interleukin 2 production. J Immunol 130 4 (1983) 1770-1773
56. Schnyder B., and Pichler W.J. Skin and laboratory tests in amoxicillin- and penicillin-induced morbilliform skin eruption. Clin Exp Allergy 30 4 (2000) 590-595
57. Phillips E.J., Sullivan J.R., Knowles S.R., et al. Utility of patch testing in patients with hypersensitivity syndromes associated with abacavir. AIDS 16 16 (2002) 2223-2225
58. Cederbrant K., Hultman P., Marcusson J.A., et al. In vitro lymphocyte proliferation as compared to patch test using gold, palladium and nickel. Int Arch Allergy Immunol 112 3 (1997) 212-217
59. Stejskal V., Hudecek R., Stejskal J., et al. Diagnosis and treatment of metal-induced side-effects. Neuro Endocrinol Lett 27 Suppl 1 (2006) 7-16
60. Lopez S., Torres M.J., Rodriguez-Pena R., et al. Lymphocyte proliferation response in patients with delayed hypersensitivity reactions to heparins. Br J Dermatol 160 2 (2009) 259-265
61. Lanier L.L., Buck D.W., Rhodes L., et al. Interleukin 2 activation of natural killer cells rapidly induces the expression and phosphorylation of the Leu-23 activation antigen. J Exp Med 167 5 (1988) 1572-1585
62. Testi R., Pulcinelli F.M., Cifone M.G., et al. Preferential involvement of a phospholipase A2-dependent pathway in CD69-mediated platelet activation. J Immunol 148 9 (1992) 2867-2871
63. Lopez-Cabrera M., Santis A.G., Fernandez-Ruiz E., et al. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J Exp Med 178 2 (1993) 537-547
64. Maino V.C., Suni M.A., and Ruitenberg J.J. Rapid flow cytometric method for measuring lymphocyte subset activation. Cytometry 20 2 (1995) 127-133
65. Pitsios C., Dimitrakopoulou A., Tsalimalma K., et al. Expression of CD69 on T-cell subsets in HIV-1 disease. Scand J Clin Lab Invest 68 3 (2008) 233-241
66. Lina G., Cozon G., Ferrandiz J., et al. Detection of staphylococcal superantigenic toxins by a CD69-specific cytofluorimetric assay measuring T-cell activation. J Clin Microbiol 36 4 (1998) 1042-1045
67. Nishio D., Izu K., Kabashima K., et al. T cell populations propagating in the peripheral blood of patients with drug eruptions. J Dermatol Sci 48 1 (2007) 25-33
68. Torres M.J., Mayorga C., Cornejo-Garcia J.A., et al. Monitoring non-immediate allergic reactions to iodine contrast media. Clin Exp Immunol 152 2 (2008) 233-238
69. Beeler A., Zaccaria L., Kawabata T., et al. CD69 upregulation on T cells as an in vitro marker for delayed-type drug hypersensitivity. Allergy 63 2 (2008) 181-188
70. Cornejo-Garcia J.A., Fernandez T.D., Torres M.J., et al. Differential cytokine and transcription factor expression in patients with allergic reactions to drugs. Allergy 62 12 (2007) 1429-1438
71. Posadas S.J., Leyva L., Torres M.J., et al. Subjects with allergic reactions to drugs show in vivo polarized patterns of cytokine expression depending on the chronology of the clinical reaction. J Allergy Clin Immunol 106 4 (2000) 769-776
72. Gaspard I., Guinnepain M.T., Laurent J., et al. Il-4 and IFN-gamma mRNA induction in human peripheral lymphocytes specific for beta-lactam antibiotics in immediate or delayed hypersensitivity reactions. J Clin Immunol 20 2 (2000) 107-116
73. Lochmatter P., Beeler A., Kawabata T.T., et al. Drug-specific in vitro release of IL-2, IL-5, IL-13 and IFN-gamma in patients with delayed-type drug hypersensitivity. Allergy (2009) [Epub ahead of print]
74. Brugnolo F., Annunziato F., Sampognaro S., et al. Highly Th2-skewed cytokine profile of beta-lactam-specific T cells from nonatopic subjects with adverse drug reactions. J Immunol 163 2 (1999) 1053-1059
75. Halevy S., Cohen A.D., and Grossman N. Clinical implications of in vitro drug-induced interferon gamma release from peripheral blood lymphocytes in cutaneous adverse drug reactions. J Am Acad Dermatol 52 2 (2005) 254-261
76. Yawalkar N., Shrikhande M., Hari Y., et al. Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. J Allergy Clin Immunol 106 6 (2000) 1171-1176
77. Posadas S.J., Torres M.J., Mayorga C., et al. Gene expression levels of cytokine profile and cytotoxic markers in non-immediate reactions to drugs. Blood Cells Mol Dis 29 2 (2002) 179-189
78. Tsuge I., Okumura A., Kondo Y., et al. Allergen-specific T-cell response in patients with phenytoin hypersensitivity; simultaneous analysis of proliferation and cytokine production by carboxyfluorescein succinimidyl ester (CFSE) dilution assay. Allergol Int 56 2 (2007) 149-155
79. Khalil G., El-Sabban M., Al-Ghadban S., et al. Cytokine expression profile of sensitized human T lymphocytes following in vitro stimulation with amoxicillin. Eur Cytokine Netw 19 3 (2008) 131-141
80. Choquet-Kastylevsky G., Intrator L., Chenal C., et al. Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome. Br J Dermatol 139 6 (1998) 1026-1032
81. Yawalkar N. Drug-induced exanthems. Toxicology 209 2 (2005) 131-134
82. Sachs B., Erdmann S., Malte Baron J., et al. Determination of interleukin-5 secretion from drug-specific activated ex vivo peripheral blood mononuclear cells as a test system for the in vitro detection of drug sensitization. Clin Exp Allergy 32 5 (2002) 736-744
83. Sachs B., Erdmann S., Al-Masaoudi T., et al. In vitro drug allergy detection system incorporating human liver microsomes in clorazepate-induced skin rash: drug-specific proliferation associated with interleukin-5 secretion. Br J Dermatol 144 2 (2001) 316-320
84. Merk H.F. Diagnosis of drug hypersensitivity: lymphocyte transformation test and cytokines. Toxicology 209 2 (2005) 217-220
85. Schmid S., Kuechler P.C., Britschgi M., et al. Acute generalized exanthematous pustulosis: role of cytotoxic T cells in pustule formation. Am J Pathol 161 6 (2002) 2079-2086
86. Le Cleach L., Delaire S., Boumsell L., et al. Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors. Clin Exp Immunol 119 1 (2000) 225-230
87. Hertl M., Bohlen H., Jugert F., et al. Predominance of epidermal CD8+ T lymphocytes in bullous cutaneous reactions caused by beta-lactam antibiotics. J Invest Dermatol 101 6 (1993) 794-799
88. Kuechler P.C., Britschgi M., Schmid S., et al. Cytotoxic mechanisms in different forms of T-cell-mediated drug allergies. Allergy 59 6 (2004) 613-622
89. Nassif A., Bensussan A., Dorothee G., et al. Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis. J Invest Dermatol 118 4 (2002) 728-733
90. Viard I., Wehrli P., Bullani R., et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282 5388 (1998) 490-493
91. Murata J., Abe R., and Shimizu H. Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment. J Allergy Clin Immunol 122 5 (2008) 992-1000
92. Chung W.H., Hung S.I., Yang J.Y., et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 14 12 (2008) 1343-1350
93. Brunner K.T., Mauel J., Cerottini J.C., et al. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14 2 (1968) 181-196
94. Sheehy M.E., McDermott A.B., Furlan S.N., et al. A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis. J Immunol Methods 249 1-2 (2001) 99-110
95. Liu L., Chahroudi A., Silvestri G., et al. Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates. Nat Med 8 2 (2002) 185-189
96. Betts M.R., Brenchley J.M., Price D.A., et al. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281 1-2 (2003) 65-78
97. Andersen M.H., Schrama D., Thor Straten P., et al. Cytotoxic T cells. J Invest Dermatol 126 1 (2006) 32-41
98. Trapani J.A., and Smyth M.J. Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2 10 (2002) 735-747
99. Dunn C., Brunetto M., Reynolds G., et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 204 3 (2007) 667-680
100. Alter G., Malenfant J.M., and Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 294 1-2 (2004) 15-22
101. Rininsland F.H., Helms T., Asaad R.J., et al. Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity. J Immunol Methods 240 1-2 (2000) 143-155
102. Boon A.C., de Mutsert G., Fouchier R.A., et al. Functional profile of human influenza virus-specific cytotoxic T lymphocyte activity is influenced by interleukin-2 concentration and epitope specificity. Clin Exp Immunol 142 1 (2005) 45-52
103. Burkett M.W., Shafer-Weaver K.A., Strobl S., et al. A novel flow cytometric assay for evaluating cell-mediated cytotoxicity. J Immunother 28 4 (2005) 396-402
104. Devevre E., Romero P., and Mahnke Y.D. LiveCount Assay: concomitant measurement of cytolytic activity and phenotypic characterisation of CD8(+) T-cells by flow cytometry. J Immunol Methods 311 1-2 (2006) 31-46
105. Rock M.T., Yoder S.M., Wright P.F., et al. Differential regulation of granzyme and perforin in effector and memory T cells following smallpox immunization. J Immunol 174 6 (2005) 3757-3764
106. Rubio V., Stuge T.B., Singh N., et al. Ex vivo identification, isolation and analysis of tumor-cytolytic T cells. Nat Med 9 11 (2003) 1377-1382
107. Shafer-Weaver K., Rosenberg S., Strobl S., et al. Application of the granzyme B ELISPOT assay for monitoring cancer vaccine trials. J Immunother 29 3 (2006) 328-335
108. van Besouw N.M., Zuijderwijk J.M., de Kuiper P., et al. The granzyme B and interferon-gamma enzyme-linked immunospot assay as alternatives for cytotoxic T-lymphocyte precursor frequency after renal transplantation. Transplantation 79 9 (2005) 1062-1066
109. Kano Y., Hirahara K., Mitsuyama Y., et al. Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption. Allergy 62 12 (2007) 1439-1444